Brief: Biocartis Announces Publication Of U.S. Studies On Idylla EGFR
Feb 2 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* PRESS NEWS BIOCARTIS GROUP NV: NEW US STUDIES DEMONSTRATE
IDYLLA™ ALLOWS RAPID FIRST ASSESSMENT OF MOST COMMON EGFR
MUTATIONS PRECEDING NEXT-GENERATION SEQUENCING
* GENEFUSION ASSAY: WE PLAN TO LAUNCH AS A RUO ASSAY IN Q1
2021
Source text for Eikon: ID:nGNE80fHdZ
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies